Skyrizi

AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Yahoo Finance
Fri, 01/31/25 - 11:23 am
AbbVie
earnings
Skyrizi
Rinvoq
AbbVie pulls off a hat trick with 3rd straight year as top TV drug ad spender, buoyed by Skyrizi and Rinvoq spots
Fierce Pharma
Thu, 01/23/25 - 12:00 pm
AbbVie
TV ads
DTC advertising
Skyrizi
Rinvoq
JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole
Clinical Trials Arena
Wed, 01/15/25 - 11:54 pm
JPMHC 2025
AbbVie
Skyrizi
Rinvoq
Humira
AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
Investors Business Daily
Wed, 10/30/24 - 08:50 pm
AbbVie
earnings
Humira
Skyrizi
Skyrizi notches top pharma, Rx brand spot for Q3 2024
Medical Marketing and Media
Mon, 10/7/24 - 09:52 pm
AbbVie
Skyrizi
Crohn's Disease
psoriatic arthritis
Skyrizi soars to top of Rx, OTC pharma brand rankings in July
Medical Marketing and Media
Tue, 08/13/24 - 11:25 am
Skyrizi
AbbVie
television ads
AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff
BioSpace
Mon, 07/29/24 - 10:31 am
AbbVie
Europe
Skyrizi
ulcerative colitis
FDA approves Abbvie's Skyrizi for ulcerative colitis
PR Newswire
Tue, 06/18/24 - 07:56 pm
AbbVie
FDA
Skyrizi
ulcerative colitis
As Humira plummets, AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B
Fierce Pharma
Fri, 02/2/24 - 11:58 am
AbbVie
earnings
Humira
Rinvoq
Skyrizi
Skyrizi goes sky-high in October among Rx, OTC pharma brands
Medical Marketing and Media
Sun, 11/12/23 - 09:19 pm
Boehringer Ingelheim
AbbVie
Skyrizi
DTC advertising
pharma advertising
Top Pharma Ad Spenders in August 2023, AbbVie Splurges to Take Top Spots
Xtalks
Sun, 10/1/23 - 01:28 pm
pharma advertising
DTC ads
AbbVie
Skyrizi
Rinvoq
Regeneron
AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial
BioSpace
Wed, 09/13/23 - 11:36 am
AbbVie
Skyrizi
JNJ
Stelara
Crohn's Disease
clinical trials
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
Fierce Pharma
Wed, 07/26/23 - 11:37 am
AbbVie
Skyrizi
Amgen
Otezla
Boehringer Ingelheim
psoriasis
AbbVie's Skyrizi posts ulcerative colitis win in maintenance study, teeing up FDA nod
Fierce Pharma
Fri, 06/16/23 - 10:12 am
AbbVie
ulcerative colitis
Skyrizi
FDA
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
Motley Fool
Fri, 03/31/23 - 10:16 am
Skyrizi
AbbVie
clinical trials
ulcerative colitis
AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus
BioSpace
Fri, 03/24/23 - 11:50 am
AbbVie
Skyrizi
ulcerative colitis
lupus
Rinvoq
clinical trials
AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda
Fierce Pharma
Thu, 03/23/23 - 11:39 am
AbbVie
Skyrizi
IBD
ulcerative colitis
clinical trials
AbbVie’s Skyrizi hits the spot in refractory psoriasis
Pharmaphorum
Mon, 03/20/23 - 11:21 am
AbbVie
Skyrizi
psoriasis
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio

Pages